March 24, 2026

Manufacturing process for Embrex^® BioDevices from Zoetis achieves ISO 9001 certification

The manufacturing site for Embrex^® BioDevices at Zoetis in Durham, North Carolina, the United States, has achieved ISO 9001 certification under the International Organization for Standardization management and services category.

This certification provides independent validation that Zoetis processes and procedures, and its culture of quality, meet the highest international standards.

"This represents a meaningful milestone for our organization," said Curt Shuey, Global Hatchery vice president at Zoetis. "Service and reliable quality have always been paramount to our business and customer relationships. This recognition reflects a foundation for continuous improvement that supports our commitment to our customers."

ISO 9001 is an internationally recognised standard for quality management systems. Certification in the management and services category reflects an organisation's commitment to quality management excellence, customer satisfaction, and continuous improvement in all aspects of operations.

Achieving ISO 9001 certification involves an independent assessment of an organisation's quality management system against the standard's requirements. Maintaining that certification involves annual third-party audits and full recertification every three years.

"Achieving ISO 9001 certification reflects the strength and discipline of our manufacturing processes," said Vandana Arestad, Diagnostics and BioDevices Platform Quality leader at Zoetis. "This accreditation validates that quality is embedded in how we manufacture and continuously improve our Embrex technology."

Additional information about this ISO certification category is available from the International Organization for Standardization at www.iso.org/sectors/management-services. Find more information about Embrex in ovo vaccination technology at www.embrex.com.

- Zoetis